Blog
NVIDIA's Earnings Beat Expectations; Stock Pops
NVIDIA (NASDAQ: NVDA) reported robust fiscal first-quarter 2021 results after the market close on Thursday, May 21.
The graphics processing unit (GPU) specialist's revenue jumped 39% year over year
IBM's New CEO Plans Layoffs
International Business Machines (NYSE: IBM) is gearing up to lay off workers amid the COVID-19 pandemic, the first such action by CEO Arvind Krishna, who took on the role in April.
IBM hasn't said
Nasdaq Today: Baidu, NetEase Stocks Fall on Delisting Fears
Major benchmarks were modestly lower on Friday morning, with most investors still showing some worry about the fragile state of the U.S. economy in the wake of the coronavirus pandemic. The Nasdaq
3 Tax Mistakes You Can't Afford to Make During the COVID-19 Crisis
COVID-19 has been wreaking havoc on the U.S. economy since cases started multiplying in March. At a time when so many people are struggling, you can't afford to fall victim to tax blunders that cost
Dow Jones Heads Lower as IBM Cuts Jobs, Apple Stock Holds Its Ground on Podcast Plans
The Dow Jones Industrial Average (DJINDICES: ^DJI) was down Friday morning ahead of the Memorial Day holiday. While many U.S. states are in the process of reopening after imposing lockdowns to slow
Potential Grubhub-Uber Deal Draws Fire Over Possible Food Delivery 'Duopoly'
With talks apparently continuing between Grubhub (NYSE: GRUB) and Uber Technologies (NYSE: UBER) over Uber's possible acquisition of the food delivery service, four senators sent a letter to the
SelectQuote Delivers Largest IPO Since February
The largest U.S. initial public offering since February did not belong to some ride-sharing service or a new biotech firm working on a coronavirus vaccine, but rather to a decades-old insurance
Eliminate These Costly Tax Mistakes Before 2021
If the economic slowdown from the measures in place to fight the coronavirus pandemic has taught us anything, it's that we all need to make the most of whatever money we have available. That makes
Buckle Inc (BKE) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
Buckle Inc (NYSE: BKE)Q1 2020 Earnings CallMay 22, 2020, 10:00 a.m. ET
Operator
Source Fool.com
Is TSMC Becoming a Pawn in the Trade War Between the U.S. and China?
TSMC (NYSE: TSM), the world's largest contract chipmaker, recently announced plans to build a new $12 billion plant in Arizona by 2024. The facility will hire 1,600 people and produce up to 20,000
Should You Own This Sleeper Biotech Stock?
The sheer volume of biotech IPOs over the past few years makes it challenging to keep up to date on all these newly public companies. Several have returned to the capital markets to load up on cash
Why Intercept Pharmaceuticals Is Plunging Today
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) are plunging on Friday after the company announced some bad news regarding its new drug application (NDA) for Ocaliva as a treatment for fibrosis
Retail Tournament: Motley Fool-Style
In this episode of Industry Focus: Consumer Goods, Emily Flippen and Fool.com contributor Dan Kline play a fun game that looks at how some retailers are doing. Get to know eight great retail
3 Stocks You Really Should Have Bought 2 Months Ago
A lot of stocks have bounced back since the coronavirus-fueled sell-off bottomed out between mid-March and early April. However, some stocks have really bounced back over the past two months. Uber
Stock Market News: Will Airline Stocks Rise When Flyers Return?
The stock market moved lower on Friday morning, with sentiment among investors taking a hit from ongoing nervousness about the reopening of the U.S. economy. Even as people start to return to work
Facebook Embraces Remote Work But Salaries Will Reflect Local Cost of Living
Facebook (NASDAQ: FB) is all in with maintaining a remote workforce once the COVID-19 pandemic is contained, saying on a Facebook Live stream in the next five to ten years half of its employees will
Better Buy: AbbVie vs. Eli Lilly
The COVID-19 pandemic has spared few companies, but AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) are two pharma giants whose businesses are thriving amid the ongoing crisis. Both drugmakers have
Here's Another Reason to Be Wary of Grubhub
My wife placed an order on Grubhub (NYSE: GRUB) from a local Italian restaurant. When it arrived, a piece of it was wrong (we received the spaghetti bolognese entree instead of the polenta bolognese
e.l.f. Beauty Rises on Strong Fourth-Quarter Sales, Wins Thumbs-Up From J.P. Morgan
A manufacturer of affordable cosmetics and skincare products, e.l.f. Beauty, Inc. (NYSE: ELF) posted some glamorous results with its latest quarterly and 12-month outcomes, reporting a 13% boost of
FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”
Gene-focused biotech bluebird bio (NASDAQ: BLUE) continues to experience prolonged difficulties in moving its flagship LentiGlobin immunotherapy for beta-thalassemia (a blood disorder that leads to
Better Buy: McDonald's vs. Yum! Brands
When looking at restaurant stocks, one could hardly find two more formidable fast-food empires than McDonald's (NYSE: MCD) and Yum! Brands (NYSE: YUM). With almost 39,000 locations and over 50,000
General Motors' Plan to Boost Pickup Production Hits a Snag: Not Enough Parts
General Motors' (NYSE: GM) plan to ramp up production of high-profit pickups has hit a snag: Short supplies of key parts from Mexico.
GM, along with the other Detroit automakers, restarted some of
Why e.l.f. Beauty Stock Jumped 11% at the Start of Trading Today
Shares of e.l.f. Beauty (NYSE: ELF) started the day with a giant leap higher, gaining as much as 11% in the first 30 minutes of the trading day. There was little doubt about why investors were so
Analyst Slashes Roku Price Target 32% Because This Is As Good as It Gets
Roku (NASDAQ: ROKU) stock is up 30% in 2020 and has nearly doubled from the lows it hit in March when the COVID-19 pandemic struck, but an analyst at investment firm Stephens thinks the streaming
Can Moderna Win the Race to Find a COVID-19 Vaccine?
With a significant portion of the world still in lockdown due to the COVID-19 pandemic, many investors are anxious about how soon a vaccine can be developed to combat the coronavirus. Currently, one


